[Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
27 sept. 2023 16h00 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hemophilia B Gene Therapy Market Size, Trends and Insights By Treatment Type...
EHang Strategically Invests in Solid-State Lithium Metal Battery Tech Company Inx to Develop Solid-State Battery Supply Chain for eVTOLs
20 sept. 2023 07h26 HE
|
EHang Holdings Limited
GUANGZHOU, China, Sept. 20, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
13 sept. 2023 03h00 HE
|
Rentschler Biopharma SE
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases
07 sept. 2023 17h00 HE
|
Shape Therapeutics, Inc.; Otsuka
TOKYO and SEATTLE, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and ShapeTX, the programmable medicine company using AI and RNA to end genetic diseases, today announce...
EHang Unmanned Aircraft Cloud System Approved by the CAAC; EH216-S Positioned for Post-TC Commercial Operations
21 août 2023 09h19 HE
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 21, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang Reports Second Quarter 2023 Unaudited Financial Results
17 août 2023 05h00 HE
|
EHang Holdings Limited
- All Planned Tests for EH216-S Type Certification Completed 100% - Strategic UAM Operational Partnership with Shenzhen Bao’an District - US$23 Million Strategic PIPE Investment to Strengthen...
Solve GNE and Genosera Sign Agreement to Develop a Novel Bicistronic AAV Gene Therapy Targeting HIBM
14 août 2023 09h00 HE
|
Solve GNE LLC
LOS ANGELES, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Solve GNE announced today that it has entered into a sponsored research agreement with Genosera to provide funding for a novel Adeno-Associated Virus...
EHang to Report Second Quarter 2023 Unaudited Financial Results on Thursday, August 17, 2023
11 août 2023 08h25 HE
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 11, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang and Shenzhen Bao’an District Form Strategic Partnership for Urban Air Mobility Operation Center
13 juil. 2023 08h32 HE
|
EHang Holdings Limited
GUANGZHOU, China, July 13, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang Announces US$23 Million Private Placement Led by South Korean Strategic Investor Lee Soo Man
11 juil. 2023 16h00 HE
|
EHang Holdings Limited
GUANGZHOU, China, July 12, 2023 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company,...